The endocytic pathway in microglia during health, aging and Alzheimer's disease

Ageing Research Reviews

Volumn 32, Issue , 2016, Pages 89-103

  Solé Domènech, Santiago ^a,b   Cruz, Dana L ^b   Capetillo Zarate, Estibaliz ^b,c,d,e   Maxfield, Frederick R ^b  

^a LUND UNIVERSITY   (Sweden)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

^d ACHUCARRO BASQUE CENTER FOR NEUROSCIENCE   (Spain)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Alzheimer's disease; Amyloid beta; Endocytosis; Lysosome; Microglia; MITF; TFEB

Indexed keywords

AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; CELL RECEPTOR;

ACIDIFICATION; AGING; ALZHEIMER DISEASE; BRAIN; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL SELECTION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; DRUG TARGETING; ENDOCYTOSIS; ENDOSOME; HOMEOSTASIS; IMMUNIZATION; INTERNALIZATION; LIPID METABOLISM; LYSOSOME; MENTAL HEALTH; MICROGLIA; ORGANELLE BIOGENESIS; PH; PHAGOCYTE; PHAGOCYTOSIS; PINOCYTOSIS; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HUMANS; LYSOSOMES; MICROGLIA; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

EID: 84978912209     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.07.002     Document Type: Review

References (212)

1. Arandjelovic, S., Ravichandran, K.S., Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16 (2015), 907–917.
2. Atagi, Y., Liu, C.C., Painter, M.M., Chen, X.F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S.S., Xu, H., Younkin, S., Das, P., Fryer, J.D., Bu, G., Apolipoprotein E is a ligand for triggering receptor expressed on myeloid cells 2 (TREM2). J. Biol. Chem. 290 (2015), 26043–26050.
3. Bamberger, M.E., Harris, M.E., McDonald, D.R., Husemann, J., Landreth, G.E., A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23 (2003), 2665–2674.
4. Banati, R.B., Rothe, G., Valet, G., Kreutzberg, G.W., Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L. Glia 7 (1993), 183–191.
5. Bard, F., Cannon, C., Barbour, R., Burke, R.L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Lieberburg, I., Motter, R., Nguyen, M., Soriano, F., Vasquez, N., Weiss, K., Welch, B., Seubert, P., Schenk, D., Yednock, T., Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6 (2000), 916–919.
6. Bernardo, A., Minghetti, L., PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr. Pharm. Des. 12 (2006), 93–109.
7. Boche, D., Denham, N., Holmes, C., Nicoll, J.A., Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis. Acta Neuropathol. 120 (2010), 369–384.
8. Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., Rivest, S., Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 132 (2009), 1078–1092.
9. Bolmont, T., Haiss, F., Eicke, D., Radde, R., Mathis, C.A., Klunk, W.E., Kohsaka, S., Jucker, M., Calhoun, M.E., Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J. Neurosci. 28 (2008), 4283–4292.
10. Bonet-Costa, V., Herranz-Perez, V., Blanco-Gandia, M., Mas-Bargues, C., Ingles, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Minarro, J., Borras, C., Garcia-Verdugo, J.M., Vina, J., Clearing amyloid-beta through PPARgamma/ApoE activation by genistein is a treatment of experimental Alzheimer's disease. J. Alzheimers Dis. 51 (2016), 701–711.
11. Booth, P.L., Thomas, W.E., Evidence for motility and pinocytosis in ramified microglia in tissue culture. Brain Res. 548 (1991), 163–171.
12. Botelho, R.J., Teruel, M., Dierckman, R., Anderson, R., Wells, A., York, J.D., Meyer, T., Grinstein, S., Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J. Cell Biol. 151 (2000), 1353–1368.
13. Bronisz, A., Sharma, S.M., Hu, R., Godlewski, J., Tzivion, G., Mansky, K.C., Ostrowski, M.C., Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors. Mol. Biol. Cell 17 (2006), 3897–3906.
14. Brown, G.C., Neher, J.J., Microglial phagocytosis of live neurons. Nat. Rev. Neurosci. 15 (2014), 209–216.
15. Budnik, V., Ruiz-Canada, C., Wendler, F., Extracellular vesicles round off communication in the nervous system. Nat. Rev. Neurosci. 17 (2016), 160–172.
16. Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C.M., Galimberti, D., Olivecrona, G., Klein, R.S., Cross, A.H., Otero, K., Piccio, L., TREM2 regulates microglial cell activation in response to demyelination in vivo. Acta Neuropathol. 129 (2015), 429–447.
17. Carey, H.A., Bronisz, A., Cabrera, J., Hildreth, B.E. 3rd, Cuitino, M., Fu, Q., Ahmad, A., Toribio, R.E., Ostrowski, M.C., Sharma, S.M., Failure to target RANKL signaling through p38-MAPK results in defective osteoclastogenesis in the microphthalmia cloudy-eyed mutant. J. Cell. Physiol. 231 (2016), 630–640.
18. Castellano, J.M., Kim, J., Stewart, F.R., Jiang, H., DeMattos, R.B., Patterson, B.W., Fagan, A.M., Morris, J.C., Mawuenyega, K.G., Cruchaga, C., Goate, A.M., Bales, K.R., Paul, S.M., Bateman, R.J., Holtzman, D.M., Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci. Transl. Med., 3, 2011, 89ra57.
19. Cataldo, A.M., Barnett, J.L., Berman, S.A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., Nixon, R.A., Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14 (1995), 671–680.
20. Chawla, A., Boisvert, W.A., Lee, C.H., Laffitte, B.A., Barak, Y., Joseph, S.B., Liao, D., Nagy, L., Edwards, P.A., Curtiss, L.K., Evans, R.M., Tontonoz, P., A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 7 (2001), 161–171.
21. Chishti, M.A., Yang, D.S., Janus, C., Phinney, A.L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., Turner, S., Lozza, G., Grilli, M., Kunicki, S., Morissette, C., Paquette, J., Gervais, F., Bergeron, C., Fraser, P.E., Carlson, G.A., George-Hyslop, P.S., Westaway, D., Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276 (2001), 21562–21570.
22. Chitu, V., Gokhan, S., Gulinello, M., Branch, C.A., Patil, M., Basu, R., Stoddart, C., Mehler, M.F., Stanley, E.R., Phenotypic characterization of a Csf1r haploinsufficient mouse model of adult-onset leukodystrophy with axonal spheroids and pigmented glia (ALSP). Neurobiol. Dis. 74 (2015), 219–228.
23. Chitu, V., Gokhan, S., Nandi, S., Mehler, M.F., Stanley, E.R., Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends Neurosci. 39 (2016), 378–393.
24. Choi, S.H., Aid, S., Caracciolo, L., Minami, S.S., Niikura, T., Matsuoka, Y., Turner, R.S., Mattson, M.P., Bosetti, F., Cyclooxygenase-1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease. J. Neurochem. 124 (2013), 59–68.
25. Chung, H., Brazil, M.I., Soe, T.T., Maxfield, F.R., Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J. Biol. Chem. 274 (1999), 32301–32308.
26. Cirrito, J.R., Kang, J.E., Lee, J., Stewart, F.R., Verges, D.K., Silverio, L.M., Bu, G., Mennerick, S., Holtzman, D.M., Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58 (2008), 42–51.
27. Combs, C.K., Johnson, D.E., Cannady, S.B., Lehman, T.M., Landreth, G.E., Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci. 19 (1999), 928–939.
28. Combs, C.K., Johnson, D.E., Karlo, J.C., Cannady, S.B., Landreth, G.E., Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPAR gamma agonists. J. Neurosci. 20 (2000), 558–567.
29. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993), 921–923.
30. Corona, A.W., Kodoma, N., Casali, B.T., Landreth, G.E., ABCA1 is necessary for bexarotene-mediated clearance of soluble amyloid beta from the hippocampus of APP/PS1 mice. J. Neuroimmune Pharmacol. 11 (2016), 61–72.
31. Corrotte, M., Chasserot-Golaz, S., Huang, P., Du, G., Ktistakis, N.T., Frohman, M.A., Vitale, N., Bader, M.F., Grant, N.J., Dynamics and function of phospholipase D and phosphatidic acid during phagocytosis. Traffic 7 (2006), 365–377.
32. Cuervo, A.M., Dice, J.F., When lysosomes get old. Exp. Gerontol. 35 (2000), 119–131.
33. Dagher, N.N., Najafi, A.R., Kayala, K.M., Elmore, M.R., White, T.E., Medeiros, R., West, B.L., Green, K.N., Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. J. Neuroinflammation, 12, 2015, 139.
34. Dai, X.M., Ryan, G.R., Hapel, A.J., Dominguez, M.G., Russell, R.G., Kapp, S., Sylvestre, V., Stanley, E.R., Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99 (2002), 111–120.
35. Davies, L.C., Jenkins, S.J., Allen, J.E., Taylor, P.R., Tissue-resident macrophages. Nat. Immunol. 14 (2013), 986–995.
36. Di Paolo, G., Kim, T.W., Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 12 (2011), 284–296.
37. Dunn, K.W., Maxfield, F.R., Delivery of ligands from sorting endosomes to late endosomes occurs by maturation of sorting endosomes. J. Cell Biol. 117 (1992), 301–310.
38. Dunn, H.C., Ager, R.R., Baglietto-Vargas, D., Cheng, D., Kitazawa, M., Cribbs, D.H., Medeiros, R., Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model. J. Alzheimers Dis. 43 (2015), 893–903.
39. Eckman, E.A., Reed, D.K., Eckman, C.B., Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J. Biol. Chem. 276 (2001), 24540–24548.
40. Eckman, E.A., Watson, M., Marlow, L., Sambamurti, K., Eckman, C.B., Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J. Biol. Chem. 278 (2003), 2081–2084.
41. Elmore, M.R., Najafi, A.R., Koike, M.A., Dagher, N.N., Spangenberg, E.E., Rice, R.A., Kitazawa, M., Matusow, B., Nguyen, H., West, B.L., Green, K.N., Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82 (2014), 380–397.
42. Fagan, A.M., Csernansky, C.A., Morris, J.C., Holtzman, D.M., The search for antecedent biomarkers of Alzheimer's disease. J. Alzheimers Dis. 8 (2005), 347–358.
43. Ferrer, I., Boada Rovira, M., Sanchez Guerra, M.L., Rey, M.J., Costa-Jussa, F., Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol. 14 (2004), 11–20.
44. Ferron, M., Settembre, C., Shimazu, J., Lacombe, J., Kato, S., Rawlings, D.J., Ballabio, A., Karsenty, G., A RANKL-PKCbeta-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev. 27 (2013), 955–969.
45. Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P., Bakhti, M., Regen, T., Hanisch, U.K., Simons, M., Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 124 (2011), 447–458.
46. Flannagan, R.S., Jaumouille, V., Grinstein, S., The cell biology of phagocytosis. Annu. Rev. Pathol. 7 (2012), 61–98.
47. Fourgeaud, L., Traves, P.G., Tufail, Y., Leal-Bailey, H., Lew, E.D., Burrola, P.G., Callaway, P., Zagorska, A., Rothlin, C.V., Nimmerjahn, A., Lemke, G., TAM receptors regulate multiple features of microglial physiology. Nature 532 (2016), 240–244.
48. Freeman, S.A., Grinstein, S., Phagocytosis: receptors, signal integration, and the cytoskeleton. Immunol. Rev. 262 (2014), 193–215.
49. Garin, J., Diez, R., Kieffer, S., Dermine, J.F., Duclos, S., Gagnon, E., Sadoul, R., Rondeau, C., Desjardins, M., The phagosome proteome: insight into phagosome functions. J. Cell Biol. 152 (2001), 165–180.
50. Gautier, E.L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K.G., Gordonov, S., Mazloom, A.R., Ma'ayan, A., Chua, W.J., Hansen, T.H., Turley, S.J., Merad, M., Randolph, G.J., Immunological Genome, C., Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13 (2012), 1118–1128.
51. Ghosh, A., Jana, M., Modi, K., Gonzalez, F.J., Sims, K.B., Berry-Kravis, E., Pahan, K., Activation of peroxisome proliferator-activated receptor alpha induces lysosomal biogenesis in brain cells: implications for lysosomal storage disorders. J. Biol. Chem. 290 (2015), 10309–10324.
52. Ginhoux, F., Prinz, M., Origin of microglia: current concepts and past controversies. Cold Spring Harb. Perspect Biol., 7, 2015, a020537.
53. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M.F., Conway, S.J., Ng, L.G., Stanley, E.R., Samokhvalov, I.M., Merad, M., Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 (2010), 841–845.
54. Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M.F., Geissmann, F., Rodewald, H.R., Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature 518 (2015), 547–551.
55. Gordon, S., Phagocytosis: an immunobiologic process. Immunity 44 (2016), 463–475.
56. Gouras, G.K., Tampellini, D., Takahashi, R.H., Capetillo-Zarate, E., Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol. 119 (2010), 523–541.
57. Grathwohl, S.A., Kalin, R.E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S.A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., Aguzzi, A., Staufenbiel, M., Mathews, P.M., Wolburg, H., Heppner, F.L., Jucker, M., Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat. Neurosci. 12 (2009), 1361–1363.
58. Graves, A.R., Curran, P.K., Smith, C.L., Mindell, J.A., The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 453 (2008), 788–792.
59. Greter, M., Lelios, I., Pelczar, P., Hoeffel, G., Price, J., Leboeuf, M., Kundig, T.M., Frei, K., Ginhoux, F., Merad, M., Becher, B., Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 37 (2012), 1050–1060.
60. Grommes, C., Lee, C.Y., Wilkinson, B.L., Jiang, Q., Koenigsknecht-Talboo, J.L., Varnum, B., Landreth, G.E., Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases. J. Neuroimmune Pharmacol. 3 (2008), 130–140.
61. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J.S., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J.C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., Hardy, J., Alzheimer genetic analysis, G., 2013.TREM2 variants in Alzheimer's disease. N. Engl. J. Med. 368 (2013), 117–127.
62. Haass, C., Selkoe, D.J., Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8 (2007), 101–112.
63. Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B., et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992), 322–325.
64. Haass, C., Kaether, C., Thinakaran, G., Sisodia, S., Trafficking and proteolytic processing of APP. Cold Spring Harb. Perspect Med., 2, 2012, a006270.
65. Hamazaki, H., Cathepsin D is involved in the clearance of Alzheimer's beta-amyloid protein. FEBS Lett. 396 (1996), 139–142.
66. Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002), 353–356.
67. Haynes, S.E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M.E., Gan, W.B., Julius, D., The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9 (2006), 1512–1519.
68. Heneka, M.T., Carson, M.J., El Khoury, J., Landreth, G.E., Brosseron, F., Feinstein, D.L., Jacobs, A.H., Wyss-Coray, T., Vitorica, J., Ransohoff, R.M., Herrup, K., Frautschy, S.A., Finsen, B., Brown, G.C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G.C., Town, T., Morgan, D., Shinohara, M.L., Perry, V.H., Holmes, C., Bazan, N.G., Brooks, D.J., Hunot, S., Joseph, B., Deigendesch, N., Garaschuk, O., Boddeke, E., Dinarello, C.A., Breitner, J.C., Cole, G.M., Golenbock, D.T., Kummer, M.P., Neuroinflammation in Alzheimer's disease. Lancet Neurol. 14 (2015), 388–405.
69. Henne, W.M., Buchkovich, N.J., Emr, S.D., The ESCRT pathway. Dev. Cell 21 (2011), 77–91.
70. Hewlett, L.J., Prescott, A.R., Watts, C., The coated pit and macropinocytic pathways serve distinct endosome populations. J. Cell Biol. 124 (1994), 689–703.
71. Hickman, S.E., Allison, E.K., El Khoury, J., Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28 (2008), 8354–8360.
72. Hoeffel, G., Ginhoux, F., Ontogeny of tissue-resident macrophages. Front. Immunol., 6, 2015, 486.
73. Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R.W., Bullock, R., Love, S., Neal, J.W., Zotova, E., Nicoll, J.A., Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372 (2008), 216–223.
74. Holowka, D., Sil, D., Torigoe, C., Baird, B., Insights into immunoglobulin E receptor signaling from structurally defined ligands. Immunol. Rev. 217 (2007), 269–279.
75. Hsieh, C.L., Koike, M., Spusta, S.C., Niemi, E.C., Yenari, M., Nakamura, M.C., Seaman, W.E., A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J. Neurochem. 109 (2009), 1144–1156.
76. Hume, D.A., The many alternative faces of macrophage activation. Front. Immunol., 6, 2015, 370.
77. Hurley, J.H., ESCRTs are everywhere. EMBO J. 34 (2015), 2398–2407.
78. Ishimoto, Y., Ohashi, K., Mizuno, K., Nakano, T., Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J. Biochem. 127 (2000), 411–417.
79. Janeway, C.J., Travers, P., Walport, M., Shlomchik, M.J., Immunobiology: The Immune System in Health and Disease. 5th ed., 2001, Garland Science, New York.
80. Jaworowski, A., Wilson, N.J., Christy, E., Byrne, R., Hamilton, J.A., Roles of the mitogen-activated protein kinase family in macrophage responses to colony stimulating factor-1 addition and withdrawal. J. Biol. Chem. 274 (1999), 15127–15133.
81. Jiang, Q., Lee, C.Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T.M., Collins, J.L., Richardson, J.C., Smith, J.D., Comery, T.A., Riddell, D., Holtzman, D.M., Tontonoz, P., Landreth, G.E., ApoE promotes the proteolytic degradation of Abeta. Neuron 58 (2008), 681–693.
82. Jiang, D., Rauda, I., Han, S., Chen, S., Zhou, F., Aggregation pathways of the amyloid beta(1–42) peptide depend on its colloidal stability and ordered beta-sheet stacking. Langmuir 28 (2012), 12711–12721.
83. Johansson, J.U., Woodling, N.S., Wang, Q., Panchal, M., Liang, X., Trueba-Saiz, A., Brown, H.D., Mhatre, S.D., Loui, T., Andreasson, K.I., Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models. J. Clin. Invest. 125 (2015), 350–364.
84. Karasinska, J.M., de Haan, W., Franciosi, S., Ruddle, P., Fan, J., Kruit, J.K., Stukas, S., Lutjohann, D., Gutmann, D.H., Wellington, C.L., Hayden, M.R., ABCA1 influences neuroinflammation and neuronal death. Neurobiol. Dis. 54 (2013), 445–455.
85. Karch, C.M., Cruchaga, C., Goate, A.M., Alzheimer's disease genetics: from the bench to the clinic. Neuron 83 (2014), 11–26.
86. Kaushik, S., Cuervo, A.M., Proteostasis and aging. Nat. Med. 21 (2015), 1406–1415.
87. Kirchhausen, T., Owen, D., Harrison, S.C., Molecular structure, function, and dynamics of clathrin-mediated membrane traffic. Cold Spring Harb. Perspect. Biol., 6, 2014, a016725.
88. Koenigsknecht-Talboo, J., Landreth, G.E., Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 25 (2005), 8240–8249.
89. Koenigsknecht-Talboo, J., Meyer-Luehmann, M., Parsadanian, M., Garcia-Alloza, M., Finn, M.B., Hyman, B.T., Bacskai, B.J., Holtzman, D.M., Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice. J. Neurosci. 28 (2008), 14156–14164.
90. Koizumi, S., Shigemoto-Mogami, Y., Nasu-Tada, K., Shinozaki, Y., Ohsawa, K., Tsuda, M., Joshi, B.V., Jacobson, K.A., Kohsaka, S., Inoue, K., UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446 (2007), 1091–1095.
91. Kondo, Y., Duncan, I.D., Selective reduction in microglia density and function in the white matter of colony-stimulating factor-1-deficient mice. J. Neurosci. Res. 87 (2009), 2686–2695.
92. Kurz, T., Terman, A., Gustafsson, B., Brunk, U.T., Lysosomes in iron metabolism, ageing and apoptosis. Histochem. Cell Biol. 129 (2008), 389–406.
93. Lakadamyali, M., Rust, M.J., Zhuang, X., Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 124 (2006), 997–1009.
94. Lange, P.F., Wartosch, L., Jentsch, T.J., Fuhrmann, J.C., ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440 (2006), 220–223.
95. Laske, C., Stransky, E., Hoffmann, N., Maetzler, W., Straten, G., Eschweiler, G.W., Leyhe, T., Macrophage colony-stimulating factor (M-CSF) in plasma and CSF of patients with mild cognitive impairment and Alzheimer's disease. Curr. Alzheimer Res. 7 (2010), 409–414.
96. Le Roy, C., Wrana, J.L., Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6 (2005), 112–126.
97. Lee, C.Y., Tse, W., Smith, J.D., Landreth, G.E., Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem. 287 (2012), 2032–2044.
98. Lefterov, I., Schug, J., Mounier, A., Nam, K.N., Fitz, N.F., Koldamova, R., RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. Neurobiol. Dis. 82 (2015), 132–140.
99. Lemke, G., Biology of the TAM receptors. Cold Spring Harb. Perspect. Biol., 5, 2013, a009076.
100. Lemmon, S.K., Clathrin uncoating: auxilin comes to life. Curr. Biol. 11 (2001), R49–52.
101. Lew, E.D., Oh, J., Burrola, P.G., Lax, I., Zagorska, A., Traves, P.G., Schlessinger, J., Lemke, G., Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Elife, 3, 2014, 23.
102. Lewis, W.H., Pinocytosis. Bull. Johns Hopkins Hosp. 49 (1931), 17–27.
103. Lim, J.P., Gleeson, P.A., Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol. Cell Biol. 89 (2011), 836–843.
104. Lin, S.X., Mallet, W.G., Huang, A.Y., Maxfield, F.R., Endocytosed cation-independent mannose 6-phosphate receptor traffics via the endocytic recycling compartment en route to the trans-Golgi network and a subpopulation of late endosomes. Mol. Biol. Cell 15 (2004), 721–733.
105. Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D., Hollenbaugh, D., Linnemann, T., Qin, M., Wong, J., Chu, K., Doberstein, S.K., Williams, L.T., Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320 (2008), 807–811.
106. Liu, Z., Condello, C., Schain, A., Harb, R., Grutzendler, J., CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-beta phagocytosis. J. Neurosci. 30 (2010), 17091–17101.
107. Liu, C.C., Kanekiyo, T., Xu, H., Bu, G., Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9 (2013), 106–118.
108. Lubke, T., Lobel, P., Sleat, D.E., Proteomics of the lysosome. Biochim. Biophys. Acta 1793 (2009), 625–635.
109. Lucin, K.M., Wyss-Coray, T., Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 64 (2009), 110–122.
110. Luzio, J.P., Hackmann, Y., Dieckmann, N.M., Griffiths, G.M., The biogenesis of lysosomes and lysosome-related organelles. Cold Spring Harb. Perspect. Biol., 6, 2014, a016840.
111. Ma, P., Mali, R.S., Munugalavadla, V., Krishnan, S., Ramdas, B., Sims, E., Martin, H., Ghosh, J., Li, S., Chan, R.J., Krystal, G., Craig, A.W., Takemoto, C., Kapur, R., The PI3K pathway drives the maturation of mast cells via microphthalmia transcription factor. Blood 118 (2011), 3459–3469.
112. MacDonald, K.P., Palmer, J.S., Cronau, S., Seppanen, E., Olver, S., Raffelt, N.C., Kuns, R., Pettit, A.R., Clouston, A., Wainwright, B., Branstetter, D., Smith, J., Paxton, R.J., Cerretti, D.P., Bonham, L., Hill, G.R., Hume, D.A., An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. Blood 116 (2010), 3955–3963.
113. Mackay, E.A., Ehrhard, A., Moniatte, M., Guenet, C., Tardif, C., Tarnus, C., Sorokine, O., Heintzelmann, B., Nay, C., Remy, J.M., Higaki, J., Van Dorsselaer, A., Wagner, J., Danzin, C., Mamont, P., A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease. Eur. J. Biochem. 244 (1997), 414–425.
114. Mahley, R.W., Rall, S.C. Jr., Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1 (2000), 507–537.
115. Mahley, R.W., Huang, Y., Weisgraber, K.H., Putting cholesterol in its place: apoE and reverse cholesterol transport. J. Clin. Invest. 116 (2006), 1226–1229.
116. Majumdar, A., Cruz, D., Asamoah, N., Buxbaum, A., Sohar, I., Lobel, P., Maxfield, F.R., Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Mol. Biol. Cell 18 (2007), 1490–1496.
117. Majumdar, A., Capetillo-Zarate, E., Cruz, D., Gouras, G.K., Maxfield, F.R., Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes. Mol. Biol. Cell 22 (2011), 1664–1676.
118. Mallet, W.G., Maxfield, F.R., Chimeric forms of furin and TGN38 are transported with the plasma membrane in the trans-Golgi network via distinct endosomal pathways. J. Cell Biol. 146 (1999), 345–359.
119. Mandrekar, S., Jiang, Q., Lee, C.Y., Koenigsknecht-Talboo, J., Holtzman, D.M., Landreth, G.E., Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J. Neurosci. 29 (2009), 4252–4262.
120. Martina, J.A., Puertollano, R., Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes. J. Cell Biol. 200 (2013), 475–491.
121. Martina, J.A., Chen, Y., Gucek, M., Puertollano, R., MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8 (2012), 903–914.
122. Martina, J.A., Diab, H.I., Li, H., Puertollano, R., Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis. Cell. Mol. Life Sci. 71 (2014), 2483–2497.
123. Martinez-Vicente, M., Sovak, G., Cuervo, A.M., Protein degradation and aging. Exp. Gerontol. 40 (2005), 622–633.
124. Masliah, E., Hansen, L., Adame, A., Crews, L., Bard, F., Lee, C., Seubert, P., Games, D., Kirby, L., Schenk, D., Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64 (2005), 129–131.
125. Maxfield, F.R., McGraw, T.E., Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5 (2004), 121–132.
126. Maxson, M.E., Grinstein, S., The vacuolar-type H(+)-ATPase at a glance − more than a proton pump. J. Cell Sci. 127 (2014), 4987–4993.
127. McMahon, H.T., Boucrot, E., Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 12 (2011), 517–533.
128. Meadows, N.A., Sharma, S.M., Faulkner, G.J., Ostrowski, M.C., Hume, D.A., Cassady, A.I., The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor. J. Biol. Chem. 282 (2007), 1891–1904.
129. Medeiros, R., Kitazawa, M., Passos, G.F., Baglietto-Vargas, D., Cheng, D., Cribbs, D.H., LaFerla, F.M., Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice. Am. J. Pathol. 182 (2013), 1780–1789.
130. Merrifield, C.J., Kaksonen, M., Endocytic accessory factors and regulation of clathrin-mediated endocytosis. Cold Spring Harb. Perspect. Biol., 6, 2014, a016733.
131. Meyer-Luehmann, M., Stalder, M., Herzig, M.C., Kaeser, S.A., Kohler, E., Pfeifer, M., Boncristiano, S., Mathews, P.M., Mercken, M., Abramowski, D., Staufenbiel, M., Jucker, M., Extracellular amyloid formation and associated pathology in neural grafts. Nat. Neurosci. 6 (2003), 370–377.
132. Mindell, J.A., Lysosomal acidification mechanisms. Annu. Rev. Physiol. 74 (2012), 69–86.
133. Moskot, M., Montefusco, S., Jakobkiewicz-Banecka, J., Mozolewski, P., Wegrzyn, A., Di Bernardo, D., Wegrzyn, G., Medina, D.L., Ballabio, A., Gabig-Ciminska, M., The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J. Biol. Chem. 289 (2014), 17054–17069.
134. Motyckova, G., Weilbaecher, K.N., Horstmann, M., Rieman, D.J., Fisher, D.Z., Fisher, D.E., Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 5798–5803.
135. Mueller-Steiner, S., Zhou, Y., Arai, H., Roberson, E.D., Sun, B., Chen, J., Wang, X., Yu, G., Esposito, L., Mucke, L., Gan, L., Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 51 (2006), 703–714.
136. Mukherjee, S., Ghosh, R.N., Maxfield, F.R., Endocytosis. Physiol. Rev. 77 (1997), 759–803.
137. Nakamichi, Y., Udagawa, N., Takahashi, N., IL-34 and CSF-1: similarities and differences. J. Bone Miner. Metab. 31 (2013), 486–495.
138. Nakanishi, H., Wu, Z., Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging. Behav. Brain Res. 201 (2009), 1–7.
139. Nakanishi, H., Microglial functions and proteases. Mol. Neurobiol. 27 (2003), 163–176.
140. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., Ikeda, K., Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541 (1991), 163–166.
141. Nandi, S., Gokhan, S., Dai, X.M., Wei, S., Enikolopov, G., Lin, H., Mehler, M.F., Stanley, E.R., The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev. Biol. 367 (2012), 100–113.
142. Nicoll, J.A., Wilkinson, D., Holmes, C., Steart, P., Markham, H., Weller, R.O., Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 9 (2003), 448–452.
143. Nicoll, J.A., Barton, E., Boche, D., Neal, J.W., Ferrer, I., Thompson, P., Vlachouli, C., Wilkinson, D., Bayer, A., Games, D., Seubert, P., Schenk, D., Holmes, C., Abeta species removal after abeta42 immunization. J. Neuropathol. Exp. Neurol. 65 (2006), 1040–1048.
144. Nishioku, T., Hashimoto, K., Yamashita, K., Liou, S.Y., Kagamiishi, Y., Maegawa, H., Katsube, N., Peters, C., von Figura, K., Saftig, P., Katunuma, N., Yamamoto, K., Nakanishi, H., Involvement of cathepsin E in exogenous antigen processing in primary cultured murine microglia. J. Biol. Chem. 277 (2002), 4816–4822.
145. Nixon, R.A., The role of autophagy in neurodegenerative disease. Nat. Med. 19 (2013), 983–997.
146. Norbury, C.C., Hewlett, L.J., Prescott, A.R., Shastri, N., Watts, C., Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity 3 (1995), 783–791.
147. Norden, D.M., Godbout, J.P., Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. 39 (2013), 19–34.
148. Ohsawa, K., Irino, Y., Nakamura, Y., Akazawa, C., Inoue, K., Kohsaka, S., Involvement of P2 × 4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 55 (2007), 604–616.
149. Pacheco-Quinto, J., Eckman, E.A., Endothelin-converting enzymes degrade intracellular beta-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J. Biol. Chem. 288 (2013), 5606–5615.
150. Pacheco-Quinto, J., Herdt, A., Eckman, C.B., Eckman, E.A., Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease. J. Alzheimers Dis. 33:Suppl 1 (2013), S101–S110.
151. Palmer, J.C., Baig, S., Kehoe, P.G., Love, S., Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta. Am. J. Pathol. 175 (2009), 262–270.
152. Paresce, D.M., Ghosh, R.N., Maxfield, F.R., Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17 (1996), 553–565.
153. Paresce, D.M., Chung, H., Maxfield, F.R., Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J. Biol. Chem. 272 (1997), 29390–29397.
154. Pillay, C.S., Elliott, E., Dennison, C., Endolysosomal proteolysis and its regulation. Biochem. J 363 (2002), 417–429.
155. Pitas, R.E., Boyles, J.K., Lee, S.H., Foss, D., Mahley, R.W., Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917 (1987), 148–161.
156. Pollard, J.W., Trophic macrophages in development and disease. Nat. Rev. Immunol. 9 (2009), 259–270.
157. Potolicchio, I., Carven, G.J., Xu, X., Stipp, C., Riese, R.J., Stern, L.J., Santambrogio, L., Proteomic analysis of microglia-derived exosomes: metabolic role of the aminopeptidase CD13 in neuropeptide catabolism. J. Immunol. 175 (2005), 2237–2243.
158. Prada, I., Furlan, R., Matteoli, M., Verderio, C., Classical and unconventional pathways of vesicular release in microglia. Glia 61 (2013), 1003–1017.
159. Racoosin, E.L., Swanson, J.A., Macropinosome maturation and fusion with tubular lysosomes in macrophages. J. Cell Biol. 121 (1993), 1011–1020.
160. Ransohoff, R.M., Cardona, A.E., The myeloid cells of the central nervous system parenchyma. Nature 468 (2010), 253–262.
161. Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L.F., Galasko, D.R., Jutel, M., Karydas, A., Kaye, J.A., Leszek, J., Miller, B.L., Minthon, L., Quinn, J.F., Rabinovici, G.D., Robinson, W.H., Sabbagh, M.N., So, Y.T., Sparks, D.L., Tabaton, M., Tinklenberg, J., Yesavage, J.A., Tibshirani, R., Wyss-Coray, T., Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13 (2007), 1359–1362.
162. Reed-Geaghan, E.G., Savage, J.C., Hise, A.G., Landreth, G.E., CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J. Neurosci. 29 (2009), 11982–11992.
163. Richardson, A., Galvan, V., Lin, A.L., Oddo, S., How longevity research can lead to therapies for Alzheimer's disease: the rapamycin story. Exp. Gerontol. 68 (2015), 51–58.
164. Roczniak-Ferguson, A., Petit, C.S., Froehlich, F., Qian, S., Ky, J., Angarola, B., Walther, T.C., Ferguson, S.M., The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal., 5, 2012, ra42.
165. Rogeberg, M., Furlund, C.B., Moe, M.K., Fladby, T., Identification of peptide products from enzymatic degradation of amyloid beta. Biochimie 105 (2014), 216–220.
166. Sadik, G., Kaji, H., Takeda, K., Yamagata, F., Kameoka, Y., Hashimoto, K., Miyanaga, K., Shinoda, T., In vitro processing of amyloid precursor protein by cathepsin D. Int. J. Biochem. Cell Biol. 31 (1999), 1327–1337.
167. Saijo, K., Glass, C.K., Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 11 (2011), 775–787.
168. Sakae, N., Liu, C.C., Shinohara, M., Frisch-Daiello, J., Ma, L., Yamazaki, Y., Tachibana, M., Younkin, L., Kurti, A., Carrasquillo, M.M., Zou, F., Sevlever, D., Bisceglio, G., Gan, M., Fol, R., Knight, P., Wang, M., Han, X., Fryer, J.D., Fitzgerald, M.L., Ohyagi, Y., Younkin, S.G., Bu, G., Kanekiyo, T., ABCA7 deficiency accelerates amyloid-β generation and Alzheimer's neuronal pathology. J. Neurosci. 36 (2016), 3848–3859.
169. Sallusto, F., Cella, M., Danieli, C., Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182 (1995), 389–400.
170. Sardiello, M., Palmieri, M., di Ronza, A., Medina, D.L., Valenza, M., Gennarino, V.A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R.S., Banfi, S., Parenti, G., Cattaneo, E., Ballabio, A., A gene network regulating lysosomal biogenesis and function. Science 325 (2009), 473–477.
171. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., Seubert, P., Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400 (1999), 173–177.
172. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D., Roses, A.D., Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 9649–9653.
173. Schwake, M., Schroder, B., Saftig, P., Lysosomal membrane proteins and their central role in physiology. Traffic 14 (2013), 739–748.
174. Settembre, C., Di Malta, C., Polito, V.A., Garcia Arencibia, M., Vetrini, F., Erdin, S., Erdin, S.U., Huynh, T., Medina, D., Colella, P., Sardiello, M., Rubinsztein, D.C., Ballabio, A., TFEB links autophagy to lysosomal biogenesis. Science 332 (2011), 1429–1433.
175. Settembre, C., Zoncu, R., Medina, D.L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M.C., Facchinetti, V., Sabatini, D.M., Ballabio, A., A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31 (2012), 1095–1108.
176. Settembre, C., De Cegli, R., Mansueto, G., Saha, P.K., Vetrini, F., Visvikis, O., Huynh, T., Carissimo, A., Palmer, D., Klisch, T.J., Wollenberg, A.C., Di Bernardo, D., Chan, L., Irazoqui, J.E., Ballabio, A., TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 15 (2013), 647–658.
177. Settembre, C., Fraldi, A., Medina, D.L., Ballabio, A., Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14 (2013), 283–296.
178. Sierra, A., Abiega, O., Shahraz, A., Neumann, H., Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front. Cell. Neurosci., 7, 2013, 6.
179. Siskova, Z., Tremblay, M.E., Microglia and synapse: interactions in health and neurodegeneration. Neural Plast., 2013, 2013, 425845.
180. Solito, E., Sastre, M., Microglia function in Alzheimer's disease. Front. Pharmacol., 3, 2012, 14.
181. Spangenberg, E.E., Lee, R.J., Najafi, A.R., Rice, R.A., Elmore, M.R., Blurton-Jones, M., West, B.L., Green, K.N., Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-beta pathology. Brain 139 (2016), 1265–1281.
182. Stauber, T., Jentsch, T.J., Chloride in vesicular trafficking and function. Annu. Rev. Physiol. 75 (2013), 453–477.
183. Steinberg, B.E., Huynh, K.K., Brodovitch, A., Jabs, S., Stauber, T., Jentsch, T.J., Grinstein, S., A cation counterflux supports lysosomal acidification. J. Cell Biol. 189 (2010), 1171–1186.
184. Steinman, R.M., Brodie, S.E., Cohn, Z.A., Membrane flow during pinocytosis. Stereol. Anal. J Cell Biol. 68 (1976), 665–687.
185. Stewart, C.R., Stuart, L.M., Wilkinson, K., van Gils, J.M., Deng, J., Halle, A., Rayner, K.J., Boyer, L., Zhong, R., Frazier, W.A., Lacy-Hulbert, A., El Khoury, J., Golenbock, D.T., Moore, K.J., CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11 (2010), 155–161.
186. Stine, W.B. Jr., Dahlgren, K.N., Krafft, G.A., LaDu, M.J., In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278 (2003), 11612–11622.
187. Sunderland, T., Mirza, N., Putnam, K.T., Linker, G., Bhupali, D., Durham, R., Soares, H., Kimmel, L., Friedman, D., Bergeson, J., Csako, G., Levy, J.A., Bartko, J.J., Cohen, R.M., Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol. Psychiatry 56 (2004), 670–676.
188. Takahashi, R.H., Milner, T.A., Li, F., Nam, E.E., Edgar, M.A., Yamaguchi, H., Beal, M.F., Xu, H.X., Greengard, P., Gouras, G.K., Intraneuronal Alzheimer A beta 42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161 (2002), 1869–1879.
189. Takahashi, K., Rochford, C.D., Neumann, H., Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201 (2005), 647–657.
190. Tanaka, Y., Matsuwaki, T., Yamanouchi, K., Nishihara, M., Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice. Neuroscience 250 (2013), 8–19.
191. Terman, A., Brunk, U.T., Lipofuscin. Int. J. Biochem. Cell Biol. 36 (2004), 1400–1404.
192. Tremblay, M.E., Lowery, R.L., Majewska, A.K., Microglial interactions with synapses are modulated by visual experience. PLoS Biol., 8, 2010, e1000527.
193. Trepanier, C.H., Milgram, N.W., Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy. J. Alzheimers Dis. 21 (2010), 1089–1099.
194. Turk, B., Dolenc, I., Lenarcic, B., Krizaj, I., Turk, V., Bieth, J.G., Bjork, I., Acidic pH as a physiological regulator of human cathepsin L activity. Eur. J. Biochem. 259 (1999), 926–932.
195. Turner, A.J., Murphy, L.J., Molecular pharmacology of endothelin converting enzymes. Biochem. Pharmacol. 51 (1996), 91–102.
196. Vanier, M.T., Niemann-Pick disease type C. Orphanet J. Rare Dis., 5, 2010, 16.
197. Vilchez, D., Saez, I., Dillin, A., The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat. Commun., 5, 2014, 5659.
198. Wahrle, S.E., Jiang, H., Parsadanian, M., Legleiter, J., Han, X., Fryer, J.D., Kowalewski, T., Holtzman, D.M., ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279 (2004), 40987–40993.
199. Wang, Y., Szretter, K.J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A.D., Diamond, M.S., Colonna, M., IL-34 is a tissue-restricted ligand of CSF1 R required for the development of Langerhans cells and microglia. Nat. Immunol. 13 (2012), 753–760.
200. Wang, Y., Cella, M., Mallinson, K., Ulrich, J.D., Young, K.L., Robinette, M.L., Gilfillan, S., Krishnan, G.M., Sudhakar, S., Zinselmeyer, B.H., Holtzman, D.M., Cirrito, J.R., Colonna, M., TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160 (2015), 1061–1071.
201. Weilbaecher, K.N., Motyckova, G., Huber, W.E., Takemoto, C.M., Hemesath, T.J., Xu, Y., Hershey, C.L., Dowland, N.R., Wells, A.G., Fisher, D.E., Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol. Cell 8 (2001), 749–758.
202. Wilcke, M., Johannes, L., Galli, T., Mayau, V., Goud, B., Salamero, J., Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-golgi network. J. Cell Biol. 151 (2000), 1207–1220.
203. Wilcock, D.M., Rojiani, A., Rosenthal, A., Levkowitz, G., Subbarao, S., Alamed, J., Wilson, D., Wilson, N., Freeman, M.J., Gordon, M.N., Morgan, D., Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J. Neurosci. 24 (2004), 6144–6151.
204. Wisniewski, T., Goni, F., Immunotherapeutic approaches for Alzheimer's disease. Neuron 85 (2015), 1162–1176.
205. Woodling, N.S., Andreasson, K.I., Untangling the web: toxic and protective effects of neuroinflammation and PGE2 signaling in Alzheimer's disease. ACS Chem. Neurosci. 7 (2016), 454–463.
206. Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N.T., Neumann, H., Walter, J., Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage. J. Biol. Chem. 288 (2013), 33027–33036.
207. Wyss-Coray, T., Mucke, L., Inflammation in neurodegenerative disease-a double-edged sword. Neuron 35 (2002), 419–432.
208. Wyss-Coray, T., Rogers, J., Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med., 2, 2012, a006346.
209. Xiao, Q., Yan, P., Ma, X., Liu, H., Perez, R., Zhu, A., Gonzales, E., Tripoli, D.L., Czerniewski, L., Ballabio, A., Cirrito, J.R., Diwan, A., Lee, J.M., Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing abeta generation and amyloid plaque pathogenesis. J. Neurosci. 35 (2015), 12137–12151.
210. Yamashiro, D.J., Maxfield, F.R., Kinetics of endosome acidification in mutant and wild-type Chinese hamster ovary cells. J. Cell Biol. 105 (1987), 2713–2721.
211. Yamashiro, D.J., Tycko, B., Fluss, S.R., Maxfield, F.R., Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell 37 (1984), 789–800.
212. Yokoyama, J.S., Wang, Y., Schork, A.J., Thompson, W.K., Karch, C.M., Cruchaga, C., McEvoy, L.K., Witoelar, A., Chen, C.H., Holland, D., Brewer, J.B., Franke, A., Dillon, W.P., Wilson, D.M., Mukherjee, P., Hess, C.P., Miller, Z., Bonham, L.W., Shen, J., Rabinovici, G.D., Rosen, H.J., Miller, B.L., Hyman, B.T., Schellenberg, G.D., Karlsen, T.H., Andreassen, O.A., Dale, A.M., Desikan, R.S., Alzheimer's Disease Neuroimaging, Association between genetic traits for immune-mediated diseases and Alzheimer disease. JAMA Neurol 73 (2016), 691–697.